Closes Oct 19, 2027$50K – $300K
Early-Stage Development of Informatics Technologies for Cancer Research and Management (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Open federal grants available in Kansas
Currently open U.S. federal opportunities that Kansas applicants can apply for, including nationwide programs. Sorted by closing date. Applications are submitted on Grants.gov.
1,455 open opportunities
Closes Oct 19, 2027Up to $650K
Limited Competition: Clinical and Translational Science Award (CTSA) Program: Collaborative and Innovative Acceleration Award (UG3/UH3 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027Up to $750K
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Assay Development and Neurotherapeutic Agent Identification (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027Up to $750K
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Development and Validation of Model Systems to Facilitate Neurotherapeutic Discovery (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 20, 2027
Innovation Grants to Nurture Initial Translational Efforts (IGNITE): Neurotherapeutic Agent Characterization and In vivo Efficacy Studies (R61/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027
National Cooperative Drug/Device Discovery/Development Groups (NCDDG) for the Treatment of Mental Disorders (U19 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (R34 Clinical Trials Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027
Cancer Prevention and Control Clinical Trials Planning Grant Program (U34 Clinical Trials Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 25, 2027Up to $375K
Research Enhancement Award Program (REAP) for Health Professional Schools and Graduate Schools (R15 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Oct 28, 2027
Mechanistic Evaluation of Therapeutic Targets derived from Treatable Traits to Improve CNS Outcomes in People with HIV (R21/R33 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 5, 2027
Limited Competition: Renewal of Existing NINDS-Supported Clinical Trial Cooperative Agreement Awards (U01 - Clinical Trials Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 5, 2027Up to $1.5M
Alzheimer's Drug-Development Program (U01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 5, 2027
Priority HIV/AIDS Research within the Mission of NIDDK (R01 Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 8, 2027
BRAIN Initiative: Theories, Models and Methods for Analysis of Complex Data from the Brain (R01 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 12, 2027
NIA Academic Leadership Career Award (K07 Independent Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 12, 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 12, 2027
Career Transition Award for NINDS Intramural Clinician-Scientists (K22 Clinical Trial Required)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 15, 2027
Toward Translation of Nanotechnology Cancer Interventions (TTNCI; R01 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 15, 2027Up to $6.3M
Leveraging Network Infrastructure to Conduct Innovative Research for Women, Children, Pregnant and Lactating Women, and Persons with Disabilities (UG3/UH3 - Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 16, 2027
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R01 - Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 16, 2027
Pilot Studies of Biological, Behavioral and Social Mechanisms Contributing to HIV Pathogenesis Within the Mission of NIDDK (R21 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 16, 2027Up to $100K
Pilot Projects Investigating Understudied Proteins Associated with Rare Diseases (R03 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 16, 2027
Basic Research in Cancer Health Disparities (R21 Clinical Trial Not Allowed)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide
Closes Nov 16, 2027Up to $200K
Innovative Screening Approaches and Therapies for Screenable Disorders in Newborns (R21 - Clinical Trial Optional)
- Agency
- National Institutes of Health
- Eligible locations
- Nationwide